Coronavirus Notebook: Moderna Vaccine First To Get GB Conditional MA, EMA To Update On AstraZeneca Blood Clot Issue

06 Apr 2021

The EU has agreed to provide ‘solidarity vaccines’ to five member states and the WHO has published a progress report on its assessments of COVID-19 vaccines.

The EMA is among agencies assessing the AZ vaccine safety issues • Source: Alamy

Moderna, Inc.’s RNA-1273 has become the first COVID-19 vaccine to receive a conditional marketing authorization (CMA) in Great Britain under a new mechanism introduced at the beginning of the year.

It has also just been launched in Wales, with the first doses to be administered from the West Wales General...